Regeneron Pharmaceuticals cash flow from investing activities for the twelve months ending March 31, 2025 was $-6.884B, a 35.14% decline year-over-year.
Regeneron Pharmaceuticals annual cash flow from investing activities for 2024 was $-2.468B, a 22.51% decline from 2023.
Regeneron Pharmaceuticals annual cash flow from investing activities for 2023 was $-3.185B, a 15.84% decline from 2022.
Regeneron Pharmaceuticals annual cash flow from investing activities for 2022 was $-3.785B, a 29.72% decline from 2021.
Regeneron Pharmaceuticals Cash Flow from Investing Activities 2010-2025 | REGN